Get started
Author

Joycelyn Entwistle

Observed name: Entwistle Joycelyn
OpenAlex ID: A5111834570
HA receptors: Regulators of signalling to the cytoskeleton
1996 · Joycelyn Entwistle, Christine L. Hall, et al. · Journal of Cellular Biochemistry · 475
A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin
2012 · Mark Kowalski, Jacinthe Guindon, et al. · The Journal of Urology · 122
Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin
2009 · Jeannick Cizeau, Danielle M. Grenkow, et al. · Journal of Immunotherapy · 79
The characterization of a human RHAMM cDNA: conservation of the hyaluronan-binding domains
1996 · Chao Wang, Joycelyn Entwistle, et al. · Gene · 68
Characterization of the murine gene encoding the hyaluronan receptor RHAMM
1995 · Joycelyn Entwistle, Shiwen Zhang, et al. · Gene · 66
Primary structure of a C-hordein gene from barley
1988 · Joycelyn Entwistle · Carlsberg Research Communications · 50
PDF
Amber codon suppression: the in vivo and in vitro analysis of two C-hordein genes from barley
1991 · Joycelyn Entwistle, S�ren Knudsen, et al. · Plant Molecular Biology · 46
Transforming Growth Factor-β1 Stimulates Multiple Protein Interactions at a Unique -Element in the 3′-Untranslated Region of the Hyaluronan Receptor RHAMM mRNA
1996 · Francis M. Amara, Joycelyn Entwistle, et al. · Journal of Biological Chemistry · 45
Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential
2012 · Joycelyn Entwistle, Jennifer G. Brown, et al. · Cancer Biotherapy and Radiopharmaceuticals · 26
Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance
2016 · Rachelle L. Dillon, Shilpa Chooniedass, et al. · Journal of Immunotherapy · 22
Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation
2011 · Arjune Premsukh, Joelle M. Lavoie, et al. · Protein Expression and Purification · 16
Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration
2009 · Jennifer Brown, Michele Rasamoelisolo, et al. · Cancer Biotherapy and Radiopharmaceuticals · 16
The Preclinical and Clinical Evaluation of VB6-845: An Immunotoxin with a De-Immunized Payload for the Systemic Treatment of Solid Tumors
2012 · Joycelyn Entwistle, Mark Kowalski, et al. · Springer eBooks · 10
A targeted proteomic approach for the identification of tumor-associated membrane antigens using the ProteomeLab™ PF-2D in tandem with mass spectrometry
2006 · Francina C. Chahal, Joycelyn Entwistle, et al. · Biochemical and Biophysical Research Communications · 7
Fusogenics: A Recombinant Immunotoxin-Based Screening Platform to Select Internalizing Tumor-Specific Antibody Fragments
2010 · Jeannick Cizeau, Marianne G.P. Torres, et al. · SLAS DISCOVERY · 6
Preclinical Safety Evaluation of Immunotoxins
2007 · Jennifer G. Brown, Joycelyn Entwistle, et al. · Wiley eBooks · 5
Preclinical Safety Evaluation of Immunotoxins
2010 · Jennifer G. Brown, Joycelyn Entwistle, et al. · Wiley eBooks · 3
Pre-clinical safety assessment of VB4-845, an EpCAM binding immunoconjugate
2008 · Crystal Marlin, Jennifer G. Brown, et al. · Cancer Research · 1
1575: A Phase I/II Study of Vicinium™ Given by Intravesical Administration in Patients with Superficial Transitional Cell Carcinoma of the Bladder: Phase I Final Results
2007 · Nicola Jones, Michael A.S. Jewett, et al. · The Journal of Urology · 1
PDF
VB1-008: Identification of a fully-human antibody specific for CD44E and CD44-isoform-3
2006 · Jeannick Cizeau, Francina C. Chahal, et al. · Cancer Research · 1
Abstract 2961: deBouganin conjugated to trastuzumab overcomes multiple mechanisms of T-DM1 drug resistance
2016 · Rachelle L. Dillon, Shilpa Chooniedass, et al. · Cancer Research
Abstract 2963: VB7-756: a Her2-specific diabody armed with deBouganin, a plant toxin with a distinct MOA
2016 · Shilpa Chooniedass, Rachelle L. Dillon, et al. · Cancer Research
oportuzumab monatoxの第II相研究:カルメット-ゲラン桿菌によって以前に治療された非浸潤性の上皮内尿路上皮癌患者に対する免疫毒素療法 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター
2012 · Kowalski Mark, Guindon Jacinthe, et al. · The Journal of Urology
Complete regression of ovarian cancer xenografts following treatment with the recombinant immunocytotoxic protein, VB6-845.
2006 · Jennifer G. Brown, Michèle Rasamoelisolo, et al. · Cancer Research
VB6-845: recombinant engineering of an Ep-CAM-specific Fab antibody for optimal delivery of de-immunized bouganin (de-bouganin)
2005 · Jeannick Cizeau, Denis G. Bosc, et al. · Cancer Research
Works count: 26
Citation count: 1,065
H-index: 12
I10-index: 13
Year
Topic
Type